NDC codes

FDA NDC Directory
Product NDC (as listed)50268-718Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50268-0718Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50268-718-13502680718135026807181330 BLISTER PACK in 1 BOX (50268-718-13) / 1 TABLET in 1 BLISTER PACK (50268-718-11)Marketed from Apr 23, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sirolimus
Generic name (nonproprietary)
sirolimus
Active ingredients
Sirolimus — 1 mg/1
Dosage form
Tablet
Route
Oral
Labeler
AvPAKNDC labeler code 50268
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 201578
Marketing start
Listing expires
Other FDA classes
Decreased Immunologic Activity (Physiologic effect)Protein Kinase Inhibitors (Mechanism)mTOR Inhibitors (Mechanism)
Identifiers
Product ID 50268-718_4cb0eea7-6bbc-aef8-e063-6294a90a7887SPL ID 4cb0eea7-6bbc-aef8-e063-6294a90a7887SPL set ID 6a85ad01-8144-4d9c-e053-2991aa0a4f85RxCUI 349208UNII W36ZG6FT64
Pharmacologic class
Kinase Inhibitor; mTOR Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450268071813 followed by a unit qualifier and the quantity

Package 50268-0718-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Sirolimus is an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged ≥13 years receiving renal transplants. Patients at low-to moderate-immunologic risk: Use initially with cyclosporine (CsA) and corticosteroids.CsA withdrawal is recommended 2 to 4 months after transplantation (1.1) . Patients at high-immunologic risk: Use in combination with CsA and corticosteroids for the first 12 months following transplantation (1.1) . Safety and efficacy of CsA withdrawal has not been established in high risk patients (1.1 , 1.2 , 14.3 ). Sirolimus is an mTOR inhibitor indicated for the treatment of patients with lymphangioleiomyomatosis (1.3). 1.1 Prophylax…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50268-718

What is NDC 50268-718?
50268-718 is the product NDC for Sirolimus, Sirolimus 1 mg/1 tablet, listed with the FDA by AvPAK. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Sirolimus.
What is the active ingredient?
Sirolimus.
Who is the labeler?
AvPAK, NDC labeler code 50268. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sirolimus?
36 other product NDCs are listed under this name. See all Sirolimus NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sirolimus NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
sirolimusSirolimus .5 mg/1Tablet, Film coatedOralAmerican Health Packaging60687-90260687-0902-21
sirolimusSirolimus .5 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-444970518-4449-00
SirolimusSirolimus 1 mg/mLSolutionOralRising Pharma Holdings, Inc.16571-80616571-0806-06
sirolimusSirolimus .5 mg/1Tablet, Film coatedOralREMEDYREPACK INC.70518-437670518-4376-00
SirolimusSirolimus 1 mg/mLSolutionOralCamber Pharmaceuticals, Inc.31722-31631722-0316-31
SirolimusSirolimus 1 mg/1TabletOralREMEDYREPACK INC.70518-379570518-3795-00
sirolimusSirolimus 1 mg/1Tablet, Film coatedOralZydus Lifesciences Limited65841-77265841-0772-0165841-0772-77
sirolimusSirolimus 2 mg/1Tablet, Film coatedOralZydus Lifesciences Limited65841-77365841-0773-0165841-0773-77
sirolimusSirolimus 1 mg/1Tablet, Film coatedOralZydus Pharmaceuticals USA Inc.68382-35168382-0351-0168382-0351-77
sirolimusSirolimus 2 mg/1Tablet, Film coatedOralZydus Pharmaceuticals USA Inc.68382-35268382-0352-0168382-0352-77

All 37 Sirolimus NDCs

Other NDCs under ANDA 201578

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201578
ProductStrengthForm · routeLabelerProduct NDC
SirolimusSirolimus 1 mg/1TabletOralDr. Reddy's Laboratories Limited55111-653
SirolimusSirolimus 2 mg/1TabletOralDr. Reddy's Laboratories Limited55111-654
SirolimusSirolimus 1 mg/1TabletOralAmerican Health Packaging68084-915
SirolimusSirolimus 1 mg/1TabletOralREMEDYREPACK INC.70518-3795

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in